| |
| |
| |
| |
Welcome to our special edition community newsletter from BioLabs LA!
BioLabs at The Lundquist Institute offers 18,000 sqft of flexible and state-of-the-art co-working lab and office space. Located on the third floor of an 80,000 sqft research facility, members have access to the amenities and resources of the entire Lundquist Institute campus.
| |
| |
Resources and Information | |
COVID-19 Resources: Funding Information And Additional Resources | We believe that life science entrepreneurs will be at the forefront of bringing innovative & timely solutions to the current Coronavirus crisis. In support of those efforts, our team has compiled an ongoing list of resources for our national network of residents.
| | | |
| |
Get Support: US Small Business Administration Disaster Loan Assistance | SBA is collecting the requested information in order to make a loan under SBA’s Economic Injury Disaster Loan Program to the qualified entities listed in this application that are impacted by the Coronavirus (COVID-19). The information will be used in determining whether the applicant is eligible for an economic injury loan. If you do not submit all the information requested, your loan cannot be fully processed.
| | | |
| |
Science Magazine: Race to find COVID-19 treatments accelerates | The World Health Organization (WHO)last week announced a major study to compare treatment strategies in a streamlined clinical trial design that doctors around the world can join. Other trials are also underway; all told, at least 12 potential COVID-19 treatments are being tested, including drugs already in use for HIV and malaria, experimental compounds that work against an array of viruses in animal experiments, and antibody-rich plasma from people who have recovered from COVID-19. | | | |
| |
Nature Magazine: Coronavirus can infect cats — dogs, not so much | Cats can be infected with the coronavirus that causes COVID-19, and can spread it to other cats, but dogs are not really susceptible to the infection, say researchers in China. The team, at Harbin Veterinary Research Institute, also concludes that chickens, pigs and ducks are not likely to catch the virus. | | | |
| |
Virtual Office Hours: Stephen M. Perry, PMP, ChemE—CEO and Founder of Kymanox | One-on-one with Stephen Perry—CEO & Founder of Kymanox, project management for the Pharmaceutical, Biotech and Medical Device Industries
| | | |
| |
Virtual Office Hours: Wilson Sonsini | One-on-one meetings with Michael Hostetler & Sabrina Poulos, partners at Wilson Sonsini, on Gene Therapy Patent Strategy Counseling.
| | | |
| |
| |
| |
| APRIL 7 | Larger Than Life Science: Bringing a Gene Therapy to Market | Executives, People Teams, and managers are all facing unprecedented uncertainties that require them to step up as leaders in new ways. In this webinar, we’re sharing our strategy and learnings to help the startup community survive and eventually thrive in today's environment. We’ll deep dive into how the Brex’s leadership and People team are prioritizing looking after customers, employees, and prioritizing runway. | | | |
| |
| APRIL 8 | Larger Than Life Science: Bringing a Gene Therapy to Market | Cell and gene therapy-related research and development in the US continue to grow at a fast rate, with the FDA signaling its interest in moving these products to clinical development. Join apanel for a discussion of the current state of gene therapy commercialization with scientist-entrepreneurs on the front lines of research and discovery. | | | |
| |
| APRIL 8 | Larger Than Life Science: Advancing Gene Therapy | New gene editing technologies have energized the science of drug discovery and sparked a wave of startups. With the advent of CRISPR/Cas9 systems, a researcher can find an active nuclease on virtually any region of the genome, greatly reducing the time needed to develop novel therapies to treat a wide range of diseases. | | | |
| |
| APRIL 8 | AAAS: Deciphering the cell cycle: The role of cell cycle control in cancer | Discover how new CDK inhibitors can be used in combination with other therapeutics to target cancer and learn about similarities and differences in critical cell cycle signaling pathways in different cancer types. | | | |
| |
| APRIL 15 | Eppendorf and Promega: Cell Seeding to Analysis - Getting the Best Out of Your Cell-based Assay | In this webinar Eppendorf and Promega are joining forces to optimize your assay results. We will have a look at the complete cell culture workflow and discuss measures you can take to get the best out of your cell-based assay. Furthermore, practical tips and tricks to avoid common pitfalls will be discussed with one of our most experienced Cell Culture Application Specialists. | | | |
| |
| APRIL 16 | Larger Than Life Science: Race For A Cure | Amidst global concerns about the coronavirus outbreak, Bay Area company ATUM is working around the clock to help find a vaccine. ATUM builds virtual models first to identify different properties of the coronavirus. In this fireside chat, hear from ATUM’s Co-Founder, Claes Gustafsson, on the technology behind the cure and how the biotech community is banding together for the collective good. | | | |
| |
APRIL 30 | Thermo Fisher Scientific: Tools and methods for CRISPR-Cas9 screening for functional genomics and drug discovery | Loss-of-function studies are an established method for uncovering a gene’s role in a biological pathway or disease state. The advent of CRISPR-Cas9 for gene knockout has given researchers a powerful tool for single-gene studies as well as high-throughput screening applications. | | | |
| |
On-Demand: New Tools for Structural Biology and Difficult to Express Proteins | In this presentation, we demonstrate the performance of a new range of Expi293 components, including engineered Expi293 cell lines to allow for regulated expression and/or glycosylation of proteins, as well as an Expi293 Methionine-deficient system for metabolic labeling of proteins for NMR or multiwavelength anomalous dispersion (MAD). | | | |
| |
On-Demand: CANCER ON A CHIP: A microfluidic 2D and 3D cell culture system for studying cellular microenvironment | At present cancer research focuses on three major areas viz. cancer diagnostics, drugs development, and next-generation therapies. About 90% of the in-vitro research rely on traditional two-dimensional (2D) monolayer cell culture systems. | | | |
| |
| |
JESSICA GRONDIN Laboratory Manager | | MARTYSE ROSARIO Office Manager | | | |
| |
| |
| |
| |
Thank you to our sponsors! | |
| |
| |
| |
| |
| |
| |
Questions? Contact us at 310-618-6999 | |
| |
.png)
